These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24984236)

  • 1. The viral make-up makes a world of difference.
    Posch W; Pfaller K; Lass-Flörl C; Wilflingseder D
    AIDS Res Hum Retroviruses; 2014 Jul; 30(7):642-3. PubMed ID: 24984236
    [No Abstract]   [Full Text] [Related]  

  • 2. Dendritic cells transfected with the nef genes of HIV-1 primary isolates specifically activate cytotoxic T lymphocytes from seropositive subjects.
    Chassin D; Andrieu M; Cohen W; Culmann-Penciolelli B; Ostankovitch M; Hanau D; Guillet JG
    Eur J Immunol; 1999 Jan; 29(1):196-202. PubMed ID: 9933101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic dendritic cell induction of HIV-specific cytotoxic T lymphocyte responses from T cells of HIV type 1-infected and uninfected individuals.
    Dupuis M; Peshwa MV; Benike C; Kundu SK; Engleman EG; Van Schooten WC; Merigan TC
    AIDS Res Hum Retroviruses; 1997 Jan; 13(1):33-9. PubMed ID: 8989425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human immunodeficiency virus type 1 replication in primary CD4(+) T lymphocytes, monocytes, and dendritic cells by cytotoxic T lymphocytes.
    Severino ME; Sipsas NV; Nguyen PT; Kalams SA; Walker BD; Johnson RP; Yang OO
    J Virol; 2000 Jul; 74(14):6695-9. PubMed ID: 10864688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viremic HIV Controllers Exhibit High Plasmacytoid Dendritic Cell-Reactive Opsonophagocytic IgG Antibody Responses against HIV-1 p24 Associated with Greater Antibody Isotype Diversification.
    Tjiam MC; Taylor JP; Morshidi MA; Sariputra L; Burrows S; Martin JN; Deeks SG; Tan DB; Lee S; Fernandez S; French MA
    J Immunol; 2015 Jun; 194(11):5320-8. PubMed ID: 25911748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic potential of CD8+ T-cells in lymphoid follicles during HIV-1 infection.
    Laman JD; van den Eertwegh AJ
    AIDS; 1992 Mar; 6(3):333-5. PubMed ID: 1567581
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV's ticket to ride: Cytotoxic T-lymphocyte-activated dendritic cells exploited for virus intercellular transfer.
    Zaccard CR; Watkins SC; Ayyavoo V; Rinaldo CR; Mailliard RB
    AIDS Res Hum Retroviruses; 2014 Nov; 30(11):1023-4. PubMed ID: 25354022
    [No Abstract]   [Full Text] [Related]  

  • 8. DC-based immunotherapy as strategy to purge the HIV reservoir?
    Søgaard OS
    EBioMedicine; 2019 May; 43():16-17. PubMed ID: 30981650
    [No Abstract]   [Full Text] [Related]  

  • 9. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant.
    Rowland-Jones SL; Nixon DF; Aldhous MC; Gotch F; Ariyoshi K; Hallam N; Kroll JS; Froebel K; McMichael A
    Lancet; 1993 Apr; 341(8849):860-1. PubMed ID: 8096564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro HIV-primed cytotoxic T-lymphocytes from seronegative individuals.
    Eissner G; Gürtler L; Eberle J; Metzger W; Wank R
    AIDS; 1992 Sep; 6(9):1048-9. PubMed ID: 1388900
    [No Abstract]   [Full Text] [Related]  

  • 11. Towards the development of a therapeutic vaccine for the treatment of HIV-1 infection: are we closer than ever?
    Egan MA
    Expert Rev Vaccines; 2007 Jun; 6(3):289-91. PubMed ID: 17542741
    [No Abstract]   [Full Text] [Related]  

  • 12. A double-blind randomized phase I clinical trial targeting ALVAC-HIV vaccine to human dendritic cells.
    Eller MA; Slike BM; Cox JH; Lesho E; Wang Z; Currier JR; Darden JM; Polonis VR; Vahey MT; Peel S; Robb ML; Michael NL; Marovich MA
    PLoS One; 2011; 6(9):e24254. PubMed ID: 21949699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T Cells.
    Smith KN; Mailliard RB; Piazza PA; Fischer W; Korber BT; Fecek RJ; Ratner D; Gupta P; Mullins JI; Rinaldo CR
    mBio; 2016 May; 7(3):. PubMed ID: 27247230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells generated from blood monocytes of HIV-1 patients are not infected and act as competent antigen presenting cells eliciting potent T-cell responses.
    Sapp M; Engelmayer J; Larsson M; Granelli-Piperno A; Steinman R; Bhardwaj N
    Immunol Lett; 1999 Mar; 66(1-3):121-8. PubMed ID: 10203044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective induction of CTL helper rather than killer activity by natural epitope variants promotes dendritic cell-mediated HIV-1 dissemination.
    Mailliard RB; Smith KN; Fecek RJ; Rappocciolo G; Nascimento EJ; Marques ET; Watkins SC; Mullins JI; Rinaldo CR
    J Immunol; 2013 Sep; 191(5):2570-80. PubMed ID: 23913962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follicular dendritic cells initiate and maintain infection of the germinal centers by human immunodeficiency virus.
    Tenner-Racz K; Racz P
    Curr Top Microbiol Immunol; 1995; 201():141-59. PubMed ID: 7587348
    [No Abstract]   [Full Text] [Related]  

  • 17. Normal immune function of monocyte-derived dendritic cells from HIV-infected individuals: implications for immunotherapy.
    Chougnet C; Cohen SS; Kawamura T; Landay AL; Kessler HA; Thomas E; Blauvelt A; Shearer GM
    J Immunol; 1999 Aug; 163(3):1666-73. PubMed ID: 10415073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co- but not Sequential Infection of DCs Boosts Their HIV-Specific CTL-Stimulatory Capacity.
    Schönfeld M; Knackmuss U; Chandorkar P; Hörtnagl P; Hope TJ; Moris A; Bellmann-Weiler R; Lass-Flörl C; Posch W; Wilflingseder D
    Front Immunol; 2019; 10():1123. PubMed ID: 31178863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential entry and productive infection of CD4 expressing lymphoid dendritic cells by macrophage-tropic HIV-1.
    Cameron PU; Lowe MG; Sotzik F; Coughlan AF; Crowe SM; Shortman K
    Adv Exp Med Biol; 1995; 378():429-33. PubMed ID: 8526110
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytotoxic T lymphocyte precursors in persons with repeated exposure to human immunodeficiency virus.
    Forthal DN
    J Infect Dis; 1999 Oct; 180(4):1406-7. PubMed ID: 10479184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.